Prevalence of Diabetic Nephropathy Among Patients with Type 2 Diabetes Mellitus in China: A Meta-Analysis of Observational Studies

Overview

Journal J Diabetes Res

Publisher Wiley

Specialty Endocrinology

Date 2020 Feb 25

PMID 32090116

Citations 83

Authors

Xin-Xin Zhang

Jun Kong

Ke Yun

Affiliations

Soon will be listed here.

Abstract

Background: Diabetic nephropathy (DN) is an important cause of end-stage renal disease and is recognized as a public health problem worldwide. However, there have been no nationwide surveys of DN prevalence in China. This study is aimed at estimating the pooled prevalence of DN among patients with type 2 diabetes in China.

Methods: Published studies on the prevalence of DN among patients with type 2 diabetes published from January 1980 to October 2019 were systematically reviewed using PubMed, Embase, Google Scholar, Chinese Wanfang databases, and Chinese National Knowledge Infrastructure. The pooled prevalence of DN was estimated with the random effects model using R software. Prevalence estimates were also stratified by study design, methodological approach, and study population characteristics.

Results: Thirty studies with a total of 79,364 participants were included in our study. The overall pooled prevalence of DN was 21.8% [95% confidence interval (CI): 18.5-25.4%]. Subgroup analysis found that the prevalence of DN varied significantly according to different DM and DN diagnostic criteria ( < 0.05); the pooling estimate was the highest in the west region of 41.3%, followed by that in the east region of China with 22.3%, northeast region with 20.7%, and central region with 15.6% ( < 0.05); the pooling estimate was the highest in the west region of 41.3%, followed by that in the east region of China with 22.3%, northeast region with 20.7%, and central region with 15.6% ( < 0.05); the pooling estimate was the highest in the west region of 41.3%, followed by that in the east region of China with 22.3%, northeast region with 20.7%, and central region with 15.6% (.

Conclusions: The prevalence of DN is high in Chinese patients with type 2 diabetes and shows geographic and gender variation. These data indicate that national strategies aimed at primary and secondary prevention of DN and screening programs for DN are urgently needed to reduce the risk and burden of DN in China.

Citing Articles

Roxadustat regulates the cell cycle and inhibits proliferation of mesangial cells via the hypoxia-inducible factor-1α/P53/P21 pathway.

Cheng Y, Yang Q, Feng B, Yang X, Jin H Front Cell Dev Biol. 2025; 13:1503477.

PMID: 40040789 PMC: 11876171. DOI: 10.3389/fcell.2025.1503477.

The role of advanced glycation end products between thyroid function and diabetic nephropathy and metabolic disorders.

Zhang Y, Wang Y, Kang Q, Chen Y, Ai L, Hu K Sci Rep. 2025; 15(1):7202.

PMID: 40021692 PMC: 11871035. DOI: 10.1038/s41598-025-88806-7.

Research progress of hypoxia-inducible factor-1α and zinc in the mechanism of diabetic kidney disease.

Qin W, Nie P, Hui X, Chen F, Hu X, Shi W Front Pharmacol. 2025; 16:1537749.

PMID: 39995420 PMC: 11847805. DOI: 10.3389/fphar.2025.1537749.

Prevalence of chronic kidney disease among Chinese adults with diabetes: a nationwide population-based cross-sectional study.

Jia W, Yu R, Wang L, Zhu D, Guo L, Weng J Lancet Reg Health West Pac. 2025; 55:101463.

PMID: 39882253 PMC: 11773038. DOI: 10.1016/j.lanwpc.2024.101463.

Dapagliflozin improves diabetic kidney disease by inhibiting ferroptosis through β-hydroxybutyrate production.

Tian Y, Zhou C, Yan Q, Li Z, Chen D, Feng B Ren Fail. 2025; 47(1):2438857.

PMID: 39746795 PMC: 11703472. DOI: 10.1080/0886022X.2024.2438857.

References

Roche M, Wang P . Factors associated with a diabetes diagnosis and late diabetes diagnosis for males and females. J Clin Transl Endocrinol. 2017; 1(3):77-84. PMC: 5685052. DOI: 10.1016/j.jcte.2014.07.002. View

Collins A, Foley R, Herzog C, Chavers B, Gilbertson D, Ishani A . Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis. 2008; 51(1 Suppl 1):S1-320. DOI: 10.1053/j.ajkd.2007.11.001. View

Elgart J, Caporale J, Asteazaran S, De La Fuente J, Camilluci C, Brown J . Association between socioeconomic status, type 2 diabetes and its chronic complications in Argentina. Diabetes Res Clin Pract. 2014; 104(2):241-7. DOI: 10.1016/j.diabres.2014.02.010. View

Weng J, Ji L, Jia W, Lu J, Zhou Z, Zou D . Standards of care for type 2 diabetes in China. Diabetes Metab Res Rev. 2016; 32(5):442-58. PMC: 5108436. DOI: 10.1002/dmrr.2827. View

Zhou Y, Guo L, Yu D, Zhou L, Wang Y, Mou Z . [Analyses on the relative factors regarding diabetic nephropathy among 1758 cases of type 2 diabetic patients]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012; 33(6):610-3. View

Zhuo L, Zou G, Li W, Lu J, Ren W . Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus. Eur J Med Res. 2013; 18:4. PMC: 3598553. DOI: 10.1186/2047-783X-18-4. View

Duan J, Wang C, Liu D, Qiao Y, Pan S, Jiang D . Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross-sectional survey. Sci Rep. 2019; 9(1):10408. PMC: 6639314. DOI: 10.1038/s41598-019-46857-7. View

Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V . Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med. 2008; 25(4):407-12. DOI: 10.1111/j.1464-5491.2008.02397.x. View

Mou S, Wang Q, Liu J, Che X, Zhang M, Cao L . Prevalence of non-diabetic renal disease in patients with type 2 diabetes. Diabetes Res Clin Pract. 2009; 87(3):354-9. DOI: 10.1016/j.diabres.2009.11.012. View

10.

Kung K, Chow K, Hui E, Leung M, Leung S, Szeto C . Prevalence of complications among Chinese diabetic patients in urban primary care clinics: a cross-sectional study. BMC Fam Pract. 2014; 15:8. PMC: 3913315. DOI: 10.1186/1471-2296-15-8. View

11.

Ritz E, Rychlik I, Locatelli F, Halimi S . End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999; 34(5):795-808. DOI: 10.1016/S0272-6386(99)70035-1. View

12.

Yu M, Lyles C, Bent-Shaw L, Young B . Risk factor, age and sex differences in chronic kidney disease prevalence in a diabetic cohort: the pathways study. Am J Nephrol. 2012; 36(3):245-51. PMC: 3510352. DOI: 10.1159/000342210. View

13.

Lim A . Diabetic nephropathy - complications and treatment. Int J Nephrol Renovasc Dis. 2014; 7:361-81. PMC: 4206379. DOI: 10.2147/IJNRD.S40172. View

14.

Guo K, Zhang L, Zhao F, Lu J, Pan P, Yu H . Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: Cross-sectional study. J Diabetes Complications. 2016; 30(5):803-10. DOI: 10.1016/j.jdiacomp.2016.03.020. View

15.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007; 335(7624):806-8. PMC: 2034723. DOI: 10.1136/bmj.39335.541782.AD. View

16.

Alcorn T, Ouyang Y . Diabetes saps health and wealth from China's rise. Lancet. 2012; 379(9833):2227-8. DOI: 10.1016/s0140-6736(12)60963-5. View

17.

Craig M, Jefferies C, Dabelea D, Balde N, Seth A, Donaghue K . ISPAD Clinical Practice Consensus Guidelines 2014. Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes. 2014; 15 Suppl 20:4-17. DOI: 10.1111/pedi.12186. View

18.

Yang L, Chu T, Lian J, Lo C, Lau P, Nan H . Risk factors of chronic kidney diseases in Chinese adults with type 2 diabetes. Sci Rep. 2018; 8(1):14686. PMC: 6168551. DOI: 10.1038/s41598-018-32983-1. View

19.

Cho N, Shaw J, Karuranga S, Huang Y, da Rocha Fernandes J, Ohlrogge A . IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138:271-281. DOI: 10.1016/j.diabres.2018.02.023. View

20.

de Hauteclocque A, Ragot S, Slaoui Y, Gand E, Miot A, Sosner P . The influence of sex on renal function decline in people with Type 2 diabetes. Diabet Med. 2014; 31(9):1121-8. DOI: 10.1111/dme.12478. View